Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson’s Disease And Schizophrenia

AIM: Parkinson’s disease and schizophrenia are clinical end points of dopaminergic deficit and excess, respectively, in the mid-brain. In accordance, current pharmacological interventions aim to restore normal dopamine levels, the overshooting of which culminates in adverse effects which results in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuropsychiatr Dis Treat
Main Authors: Gupta, Ashish Kumar, Pokhriyal, Ruchika, Khan, Mohd Imran, Kumar, Domada Ratna, Gupta, Rishab, Chadda, Rakesh Kumar, Ramachandran, Rashmi, Goyal, Vinay, Tripathi, Manjari, Hariprasad, Gururao
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6781638/
https://ncbi.nlm.nih.gov/pubmed/31632033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S214217
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados